𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Plasma concentrations of vascular endothelial growth factor are associated with peripheral oedema in patients treated with thiazolidinedione

✍ Scribed by M. Emoto; N. Fukuda; Y. Nakamori; A. Taguchi; S. Okuya; Y. Oka; Y. Tanizawa

Book ID
105818429
Publisher
Springer
Year
2006
Tongue
English
Weight
69 KB
Volume
49
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Vascular endothelial growth factor level
Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome
✍ M. Γ‡ekmen; C. Evereklioglu; H. Er; H. S. InalΓΆz; S. Doganay; ; I. H πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 124 KB

## Abstract **Background/aims** Vascular endothelial growth factor (VEGF) is a cytokine participating in inflammation with potent endothelial cell effects. It is produced by macrophages, neutrophils and vascular endothelial cells and can alter vessel permeability. Behçet's syndrome is a systemic in

Clinical factors associated with outcome
Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
✍ Toni K. Choueiri; Jorge A. Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Al πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Therapy targeted against the vascular endothelial growth factor (VEGF) pathway is a standard of care for patients with metastatic renal cell carcinoma (RCC). The identification of patients who are more likely to benefit from these agents is warranted. ## METHODS. In to